Dr. Hans Binder is a founding managing director of the Interdisciplinary Centre for Bioinformatics (IZBI), a central research unit established at the University of Leipzig for the purpose of promoting research and education in genome bioinformatics. He has subsequently served as the Principal Investigator for Bioinformatics and Systems Biology projects in various consortial studies tackling different types of cancer, such as the International Cancer Genome Consortium, the German Glioma Network, and the German Lymphoma Alliance, along with other diseases like Community Acquired Pneumonia, and LIFE, a comprehensive health study of Leipzig's population. In recent years, his group has been focusing on single cell omics studies on cancer, as well as immune and stroma cell populations. From a methodological standpoint, his group (https://www.izbi.uni-leipzig.de/science/research-groups/binder/) has created analysis pipelines for high-dimensional omics and phenotype data in systems biology environments, utilizing machine learning and statistical methodologies. Dr. Binder has co-authored approximately 300 scientific publications in high-ranked scientific journals.

For over a decade, Dr. Binder and his team have maintained a fruitful collaboration with the Institute of Molecular Biology NA RA, involving annual staff exchanges, co-supervision of PhD and capstone theses, and over 25 joint scientific publications, making this international partnership one of Armenia's most productive. He received an honorary doctorate from the Russian-Armenian University in 2022 and assumed the roles of Chairman of the Board of Trustees at the Armenian Bioinformatics Institute in 2021 and group leader (https://abi.am/research/research-labs/binder-lab/).